Page last updated: 2024-09-03

23-seleno-25-homotaurocholic acid and Benign Neoplasms

23-seleno-25-homotaurocholic acid has been researched along with Benign Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andreyev, HJN; Gee, C; Jackson, A; Kabir, M; Lalji, A; Muls, A; Shaw, C; Vyoral, S1

Other Studies

1 other study(ies) available for 23-seleno-25-homotaurocholic acid and Benign Neoplasms

ArticleYear
The efficacy of a low-fat diet to manage the symptoms of bile acid malabsorption - outcomes in patients previously treated for cancer.
    Clinical medicine (London, England), 2017, Volume: 17, Issue:5

    Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Bile Acids and Salts; Diarrhea; Diet, Fat-Restricted; Female; Humans; Male; Middle Aged; Neoplasms; Prospective Studies; Steatorrhea; Taurocholic Acid; Tomography, X-Ray Computed; Treatment Outcome; Young Adult

2017